EFIENT

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Tunisia, United Kingdom, South Africa

Active ingredients

The drug EFIENT contains one active pharmaceutical ingredient (API):

1 Prasugrel UNII G89JQ59I13 - PRASUGREL HYDROCHLORIDE

Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke. Read about Prasugrel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EFIENT Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC22	Prasugrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 05386702, 05743527, 05871834, 05906484, 06562414, 06568693, 06568701, 07580526, 07668273, 07745186, 07745192, 09188844, 09188867, 09188896, 09188910, 09276198, 09276206, 09902365, 10535914, 11309634, 11861610, 12505840, 12505857, 12593198, 12652328, 12652340, 14266322, 14266339, 14355994, 16354668, 16768619, 17390123, 17541042
Country: EE	Ravimiamet	Identifier(s): 1412862, 1412941, 1412963, 1412974, 1412985, 1412996, 1413009, 1413010, 1413021, 1413032, 1413043, 1413054, 1413065, 1413076
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08503002, 08503009, 08503013
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 034468, 034479
Country: FR	Base de données publique des médicaments	Identifier(s): 65916489
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 152403, 152412, 374349, 374414, 381317, 386063
Country: IE	Health Products Regulatory Authority	Identifier(s): 13741, 13809, 13856, 27007
Country: IT	Agenzia del Farmaco	Identifier(s): 039055025, 039055090
Country: JP	医薬品医療機器総合機構	Identifier(s): 3399009F1020, 3399009F2026, 3399009F3022, 3399009F5025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1036507, 1036508, 1036509, 1036510, 1036511, 1036512, 1036513, 1036514, 1036515, 1036516, 1036517, 1036518, 1036519, 1036520, 1063748, 1063749
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 90530, 90549
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100206170, 100206187
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62438001, W62438002, W62438003, W62438004, W62438005, W62438006, W62438007, W62439001, W62439002, W62439003, W62439004, W62439005, W62439006, W62439007
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12073011, 12073012
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/8.2/0242, 43/8.2/0243